EX1 0.57% 87.5¢ exopharm limited

Ann: December 2018 Quarterly Cash Flow Report, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 48 Posts.
    lightbulb Created with Sketch. 3
    Being a shareholder myself who thinks the clinic trials will come back a good result? I do judging by there anaylsis so far!
 
watchlist Created with Sketch. Add EX1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.